Ịṅomi vasculogenic
Ihe nnomi onye akwa vaskulojenic bụ mmepụta nke ọwa microvascular site na mkpụrụ ndụ akpụ na-eme ihe ike, metastatic na mkpụrụ ndụ ihe nketa.[1][2] Usoro a dị iche na angiogenesis n'ihi na ọ na-eme de novo na-enweghị ọnụnọ nke mkpụrụ ndụ endothelial (mkpụrụ ndụ ọgbụgba na agbanye n'ụgbọ ma na-eṅomi ezigbo endothelium vascular).[3] Maniotis et al. kọwara ya na uveal melanomas na 1999.[4] Mgbe emesịrị na ọtụtụ ụdị akpụ ndị ọzọ.[5][6] E nwere ụdị abụọ dị mkpa nke vasculogenic mimicry: towa afọ na ọkara Nke mbụ yiri nke ọbara nkịtị, ebe nke ikpeazụ dị iche n'ụzọ doro anya ọ bụ ezie na ọ nwere ike ịnata anastomosis na akwara ọbara. Akọwaala usoro na ụzọ mgbaàmà nke na-etinye aka na usoro nke vasculogenic mimicry.[7]
Akụkọ mgbe gara-aga[dezie | dezie ebe o si]
Mgbe a chọtara ya na 1999 esemokwu bilitere n'ọhịa banyere izi ezi nke nchọpụta na nkwubi okwu nke Maniotis na ndị ọrụ ibe ya.[8] Ka o sina dị, ọtụtụ ìgwè ndị na-eme nchọpụta akwadowo nchọpụta ha, na-aghọ ihe na-adọrọ mmasị dị ukwuu n'ihi ọrụ ya nwere ike ịbụ ihe na-agwọ ọrịa na ihe na-egosi metastasis.[9]
Lekwaa[dezie | dezie ebe o si]
- Vaskulojenis
Edensibia[dezie | dezie ebe o si]
- ↑ Folberg (February 2000). "Vasculogenic mimicry and tumor angiogenesis.". The American Journal of Pathology 156 (2): 361–81. DOI:10.1016/s0002-9440(10)64739-6. PMID 10666364.
- ↑ Folberg (July–August 2004). "Vasculogenic mimicry.". APMIS 112 (7–8): 508–25. DOI:10.1111/j.1600-0463.2004.apm11207-0810.x. PMID 15563313.
- ↑ Kpọpụta njehie: Invalid
<ref>tag; no text was provided for refs named:0 - ↑ Maniotis (September 1999). "Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry.". The American Journal of Pathology 155 (3): 739–52. DOI:10.1016/s0002-9440(10)65173-5. PMID 10487832.
- ↑ Van der Schaft, D.W.J., Hillen, F., Pauwels, P., Kirschmann, D.A., Castermans, K., Oude Egbrink, M.G.A, Tran, M.G.B., Sciot, R., Hauben, E., Hogendoorn, P.C.W., Delattre, O., Maxwell, P.H., Hendrix, M.J.C., Griffioen, A.W. Effects of angiogenesis inhibitors on vascular network formation by human endothelial and melanoma cells. Cancer Res. 2003, 96:1473-7. doi: 10.1158/0008-5472.CAN-05-2468
- ↑ Hillen, F. & Griffioen, A.W. Tumour vascularization: sprouting angiogenesis and beyond. Cancer Metastasis Rev. 2007, 26:489-502. doi: 10.1007/s10555-007-9094-7
- ↑ Paulis, Y.W.J., Soetekouw, P.M.M.B., Verheul H.M.W., Tjan-Heijnen, V.C.G., Griffioen, A.W. Signalling pathways in vasculogenic mimicry. Biochem. Biophys. Acta 2010, 1806:18-28. doi: 10.1016/j.bbcan.2010.01.001
- ↑ Fausto (February 2000). "Vasculogenic Mimicry in Tumors". The American Journal of Pathology 156 (2): 359. DOI:10.1016/S0002-9440(10)64738-4. PMID 10666363.
- ↑ Seftor (October 2012). "Tumor cell vasculogenic mimicry: from controversy to therapeutic promise.". The American Journal of Pathology 181 (4): 1115–25. DOI:10.1016/j.ajpath.2012.07.013. PMID 22944600.
Ihe ọgụgụ ndị ọzọ[dezie | dezie ebe o si]
- [Ihe e dere n'ala ala peeji] Molecular Phenotypes nke Endothelial Cells na Malignant Tumors. Na: Akslen, L.A., Watnick, R.S. (eds) Biomarkers of the Tumor Microenvironment. [Ihe e dere n'ala ala peeji]
- Fan (August 2013). "A new perspective of vasculogenic mimicry: EMT and cancer stem cells (Review)". Oncology Letters 6 (5): 1174–1180. DOI:10.3892/ol.2013.1555. PMID 24179490.
- Kirschmann (April 2012). "Molecular Pathways: Vasculogenic Mimicry in Tumor Cells: Diagnostic and Therapeutic Implications". Clinical Cancer Research 18 (10): 2726–2732. DOI:10.1158/1078-0432.CCR-11-3237. PMID 22474319.
- Qiao (February 2015). "Advanced research on vasculogenic mimicry in cancer". Journal of Cellular and Molecular Medicine 19 (2): 315–326. DOI:10.1111/jcmm.12496. PMID 25598425.